Diabetes is a chronic disease that affects millions of people globally. It occurs when the body cannot produce enough insulin or cannot use insulin effectively, resulting in high levels of glucose in the blood.

According to the World Health Organization, an estimated 422 million people had diabetes in 2014, and the prevalence has been increasing over the years.

The good news is that diabetes is manageable, and there are various ways to control it, such as medications, lifestyle changes, and regular monitoring.

However, there is still a need for continuous research and development of innovative treatments and solutions to help people with diabetes lead healthy and productive lives. This is where MSD, a global healthcare company, comes in.

MSD’s Commitment to Diabetes Care

MSD, also known as Merck & Co. Inc., is a leading healthcare company that aims to improve the world’s health and well-being. One of MSD’s focus areas is diabetes care, and it has been committed to this cause for over 100 years.

MSD’s mission is to discover, develop, and deliver innovative medicines, vaccines, and solutions that save and improve lives.

MSD’s approach to diabetes care is holistic and patient-centered. It recognizes that diabetes affects each person differently and that treatment plans should be tailored to the individual’s needs.

MSD’s diabetes care products and programs aim to provide people with diabetes the tools and support they need to manage their condition effectively.

MSD’s Diabetes Care Products and Programs

MSD has a wide range of products and programs for diabetes care, including:.

Januvia (Sitagliptin) and Janumet (Sitagliptin and Metformin HCl)

Januvia is an oral medication that is used to lower blood sugar levels in people with type 2 diabetes.

It works by increasing the levels of incretin hormones in the body, which stimulate the pancreas to produce more insulin and reduce the amount of glucose produced by the liver. Janumet combines Januvia with metformin, another medication used to lower blood sugar levels. Together, Januvia and Janumet provide a simple and effective way to manage blood sugar levels, along with a balanced diet and exercise.

Dulaglutide (Trulicity)

Dulaglutide is an injectable medication that is used to lower blood sugar levels in people with type 2 diabetes. It works by mimicking the effects of GLP-1, a hormone that stimulates insulin secretion and suppresses glucagon secretion.

Dulaglutide can be taken once a week, which may offer convenience for people with busy lifestyles.

MSD for Mothers

MSD for Mothers is a global initiative that aims to improve maternal health and reduce maternal mortality, including among women with gestational diabetes.

The program focuses on improving access to quality care, strengthening health systems, and advancing innovative treatments and solutions.

Laws and Policies

MSD is committed to advocating for laws and policies that support diabetes care and management. It works with governments, policymakers, and other stakeholders to promote access to affordable and high-quality care for people with diabetes.

MSD’s Diabetes Research and Development

MSD has a robust research and development (R&D) program for diabetes, with a focus on discovering new treatments, improving existing ones, and advancing technologies.

MSD’s R&D efforts are driven by the need to address the unmet needs of people with diabetes and improve their quality of life.

MSD’s diabetes R&D encompasses various fields, including:.

Insulin and GLP-1 Analogs

MSD is researching and developing new insulin and GLP-1 analogs, which can provide more options and flexibility for people with diabetes. These analogs aim to improve glycemic control while minimizing side effects, such as hypoglycemia and weight gain.

Biomarkers and Diagnostics

MSD is investing in the development of biomarkers and diagnostics that can aid in the early detection and management of diabetes.

These tools can help identify people at high risk for developing diabetes, monitor the progression of the disease, and guide treatment decisions.

E-Health and Digital Technologies

MSD is exploring the use of e-health and digital technologies to improve diabetes management and self-care.

These technologies include mobile apps, wearables, and digital platforms that can help people track their glucose levels, manage their medications, and connect with healthcare providers.

MSD’s Diabetes Care Partnerships

MSD recognizes that diabetes care requires a collaborative effort and is therefore engaged in various partnerships with healthcare providers, patient organizations, and other stakeholders.

These partnerships aim to promote awareness, improve access to care, and advance diabetes research and development.

The American Diabetes Association (ADA)

MSD partners with the ADA to support its mission of preventing and curing diabetes and improving the lives of people affected by diabetes.

MSD provides funding for the ADA’s research and advocacy programs and participates in its educational initiatives and events.

The International Diabetes Federation (IDF)

MSD works with the IDF to support its mission of promoting diabetes care, prevention, and a cure worldwide. MSD provides funding for the IDF’s research and advocacy programs and participates in its international events and campaigns.

Global Health Partnerships

MSD is involved in various global health partnerships that aim to improve diabetes care in low- and middle-income countries.

These partnerships focus on building local capacity, strengthening health systems, and advancing diabetes prevention and management.

The Future of Diabetes Care with MSD

MSD’s commitment to diabetes care is unwavering, and its efforts in research, development, and partnerships are poised to make a significant impact on the lives of people with diabetes worldwide.

MSD’s goal is not only to provide effective solutions and treatments for diabetes but also to advocate for policies and systems that promote diabetes care and prevent its complications. With MSD’s global efforts and collaborations, a world where diabetes is well managed and prevented is within reach.